Difference between revisions of "Team:Pasteur Paris/Results"

Line 198: Line 198:
 
<div class="text1">
 
<div class="text1">
 
<p>
 
<p>
</a>Then, we investigated whether our protein was able to catalyze the <B>biosilification reaction</B>. To do that, we drew inspiration for the <a href="https://2011.igem.org/Team:Minnesota"><B>2011 Minnesota iGEM team</B></a> and their work about <B>Si4</B> to evaluate the silification process. First, we used a source of silicic acid, the tetraethyl orthosilicate (<B>TEOS</B>), which is an inactive form of silicic acid. By activating it in acidic conditions, we released the free silicic acid (Fig. 9A). After incubation with or without our fusion protein, we determined the <B>quantity of free silicic acid</B> by a spectrophotometric method, since biosilification process consumes silicic acid to form silica (Fig. 9B). We clearly observed a precipitation into the test tube, instead of the negative control (Fig. 10A). By quantifying it by <B>molybdate assay</B> using a <B>standard curve</B> (Fig. 10B), we deduced the corresponding mass of silicic acid left after silification: 33 &micro;g. Before silification, the concentration was 208 &micro;g/ml. The fusion protein led to the production of 175 &micro;g of silica after 2 hours. Therefore, the silification yield after two hours is up to 84% with the C2 protein whereas the yield without the protein is 0% (Fig. 10C). We concluded that our protein worked.
+
</a>Then, we investigated whether our protein was able to catalyze the <B>biosilification reaction</B>. To do that, we drew inspiration for the <a href="https://2011.igem.org/Team:Minnesota"><B>2011 Minnesota iGEM team</B></a> and their work about <B>Si4</B> to evaluate the silification process. First, we used a source of silicic acid, the tetraethyl orthosilicate (<B>TEOS</B>), which is an inactive form of silicic acid. By activating it in acidic conditions, we released the free silicic acid (Fig. 9A). After incubation with or without our fusion protein, we determined the <B>quantity of free silicic acid</B> by a spectrophotometric method, since biosilification process consumes silicic acid to form silica (Fig. 9B). We clearly observed a precipitation into the test tube, instead of the negative control (Fig. 10A). By quantifying it by <B>molybdate assay</B> using a <B>standard curve</B> (Fig. 10B), we deduced the corresponding mass of silicic acid left after silification: 33 &micro;g. Before silification, the concentration was 208 &micro;g/ml. The fusion protein led to the production of 175 &micro;g of silica after 2 hours. Therefore, the silification yield after two hours is up to 84% with the C2 protein whereas the yield without the protein is 0% (Fig. 10C). We concluded that our protein worked. </br>
 
<img src="https://static.igem.org/mediawiki/2016/2/20/T--Pasteur_Paris--Results9.png" width="100%"  alt="image"/></img>
 
<img src="https://static.igem.org/mediawiki/2016/2/20/T--Pasteur_Paris--Results9.png" width="100%"  alt="image"/></img>
 
  </p>
 
  </p>
Line 253: Line 253:
 
<div class="text1">
 
<div class="text1">
 
<p>
 
<p>
Our patch aims at detecting mosquito-borne pathogen antigens. Since the composite patch-protein was not completely assembled, we characterized the efficiency of our detection method by using commercial membranes of PVDF or nitrocellulose. The detection method we designed was based on the conjugation of antigens with the HRP, and the capture of these conjugated antigens by specific antibodies.  We revealed interactions by incubating membranes with the HRP’s substrate.</br></br>
+
Our patch aims at detecting <B>mosquito-borne pathogen antigens</B>. Since the composite patch-protein was not completely assembled, we characterized the <B>efficiency of our detection method</B> by using commercial membranes of PVDF or nitrocellulose. The detection method we designed was based on the <B>conjugation</B> of <B>antigens</B> with the Horse radish peroxydase enzyme <B>HRP</B>, and the capture of these conjugated antigens by specific antibodies.  We revealed the interactions by incubating membranes with the HRP’s substrate.</br></br>
First, we tested whether our detection method was working by using single purified viral protein of yellow fever virus (YFVp). By incubating coated membranes with conjugated HRP-BSA, single EZ, or non conjugated YFVp, we didn’t observe any signal (Fig. 11). However, in presence of conjugated HRP-YFVp, a dark spot appeared (Fig. 11). Thus showing that we were able to detect YFVp by this immunodetection technique. </br></br>
+
First, we tested whether our detection method was working by using <B>single purified viral protein</B> of yellow fever virus (<B>YFVp</B>). By incubating coated membranes with conjugated HRP-BSA, single EZ, or non conjugated YFVp, we didn’t observe any signal (Fig. 11). However, in presence of <B>conjugated HRP-YFVp</B>, a dark spot appeared (Fig. 11). Thus showing that we were able to <B>detect YFVp</B> by this immunodetection technique. </br></br>
 
<center><img src="https://static.igem.org/mediawiki/2016/2/25/T--Pasteur_Paris--Results11.png" width="80%"  alt="image"/></img></center>
 
<center><img src="https://static.igem.org/mediawiki/2016/2/25/T--Pasteur_Paris--Results11.png" width="80%"  alt="image"/></img></center>
 
  </p>
 
  </p>
Line 270: Line 270:
 
<p>
 
<p>
 
Then, in the presence of an excess of non-specific proteins such as BSA, we showed that we maintained the specificity of our detection method (data not shown). </br></br>
 
Then, in the presence of an excess of non-specific proteins such as BSA, we showed that we maintained the specificity of our detection method (data not shown). </br></br>
To determine whether mosquito proteins can interfere with the specific interaction between viral proteins and specific antibodies, we coated PVDF membranes with CHIKV-specific antibodies, and we conjugated CHIKV envelope protein in presence of an excess of mosquito proteins (from non infected mosquitoes). Then, we incubated coated membranes with conjugated mosquito proteins in the presence or absence of CHIKV envelope protein. We noted a basal level of interaction between the CHIKV-specific antibody 3E4 and mosquito proteins (Fig. 12). However, we noted an important increase of signal when CHIKV envelope protein is present in the mixture. It is obvious that we have to improve the specificity of our detection method in the presence of mosquito lysate. </br></br>
+
To determine whether mosquito proteins can interfere with the specific interaction between viral proteins and specific antibodies, we coated PVDF membranes with CHIKV-specific antibodies, and we conjugated CHIKV envelope protein in presence of an <B>excess of pathogen-free mosquito proteins</B>. Then, we incubated coated membranes with conjugated mosquito proteins in the presence or absence of CHIKV envelope protein. We noted a <B>basal level</B> of interaction between the CHIKV-specific antibody 3E4 and mosquito proteins (Fig. 12). However, we noted an important <B>increase of signal</B> when <B>CHIKV envelope protein is present</B> in the mixture. It is obvious that we have to improve the specificity of our detection method in the presence of mosquito lysate. </br></br>
 
<img src="https://static.igem.org/mediawiki/2016/0/00/T--Pasteur_Paris--Results12.png" width="100%"  alt="image"/></img>
 
<img src="https://static.igem.org/mediawiki/2016/0/00/T--Pasteur_Paris--Results12.png" width="100%"  alt="image"/></img>
 
  </p>
 
  </p>
Line 284: Line 284:
 
<div class="text2">
 
<div class="text2">
 
<p>
 
<p>
However, these results showed that our detection method worked. We plan to determine the sensitivity of the method by using different amounts of CHIKV envelope proteins in the mixture.  
+
In addition to the fact that these results showed that our detection method worked, we also plan to determine the sensitivity of the method by using different amounts of CHIKV envelope proteins in the mixture.  
Finally, when patches became available, we repeated the experiment on the composite patches (cellulose-silica + fusion protein). By replacing the membrane by the patch, we observed the presence of signal when CHIKV envelope protein is present, but non-specific interactions are clearly visible (Fig. 13). We can explain this observation by the fact that it was difficult to wash patches since they are brittle, Moreover, heterogeneity of degradation between the patches contributed to the fact that we cannot come to a conclusion (signal intensity was measured by mean intensity in regions of interests). In parallel, we did the same experiment to detect YFV envelope protein into infected mosquitoes (day 11 post-infection). As previously, no conclusion can be drawn.  
+
Finally, when <B>patches became available</B> after pressure assembly of <B>cellulose-C2 protein</B>, we repeated the immuno dection assay experiment on the composite patches (cellulose-silica + fusion protein). By replacing the membrane by the patch, <B>we observed a signal</B> when CHIKV envelope protein is present, but <B>non-specific interactions</B> are clearly visible (Fig. 13). We can explain this observation by the fact that it was difficult to wash patches since they a little brittle in full liquid shaking conditions. A better packaged version, with vertical flow could improve the fluidics and stability of the experiment. Moreover, heterogeneity of degradation between the patches contributed to the fact that we cannot come to a conclusion (signal intensity was measured by mean intensity in regions of interests). In parallel, we did the same experiment to detect <B>YFV envelope protein</B> into infected mosquitoes (day 11 post-infection) (Performed by a coach with BHS clearance, see Safety conditions). As previously, no conclusion can be drawn. </br>
 
<img src="https://static.igem.org/mediawiki/2016/b/bc/T--Pasteur_Paris--Results13.png" width="100%"  alt="image"/></img>
 
<img src="https://static.igem.org/mediawiki/2016/b/bc/T--Pasteur_Paris--Results13.png" width="100%"  alt="image"/></img>
 
  </p>
 
  </p>
Line 294: Line 294:
 
<B>Figure 13. Immunodetection of envelope protein of CHIKV or YFV using the composite patch </B>
 
<B>Figure 13. Immunodetection of envelope protein of CHIKV or YFV using the composite patch </B>
 
  Immunodetection of E(CHIKV) in presence of mosquito proteins onto coated-composite patches. Histograms : 1, 2, 3: mosquito lysate + E(CHIKV); 4: mosquito lysate + diluted E(CHIKV).  
 
  Immunodetection of E(CHIKV) in presence of mosquito proteins onto coated-composite patches. Histograms : 1, 2, 3: mosquito lysate + E(CHIKV); 4: mosquito lysate + diluted E(CHIKV).  
Immunodetection of E(YFV) into infected mosquitoes onto coated-composite patches. Histograms : 1, 2, 3: YFV-infected mosquitoes; 4: non infected mosquitoes.
+
Immunodetection of E(YFV) into infected mosquitoes onto coated-composite patches. Histograms : 1, 2, 3: YFV-infected mosquitoes; 4: non infected mosquitoes.</br>
  
 
</br></br>
 
</br></br>
Line 303: Line 303:
 
<div class="text1">
 
<div class="text1">
 
<p>
 
<p>
Using similar approaches as in the trap design, a prototype for an analysis station has been 3D printed. It allows us to visualize the analysis process and ergonomy. Sample throughput in the system remains to be tested.  
+
Using similar approaches as in the trap design, a <B>prototype</B> for an <B>analysis station</B> has been <B>3D printed</B>. It allows us to visualize the analysis process and ergonomy. Sample throughput in the system remains to be tested. </br>
 
</p>
 
</p>
 
</div>
 
</div>
Line 311: Line 311:
 
<div class="text1">
 
<div class="text1">
 
<p>
 
<p>
With collaborations, public education, public opinion, polling, we were able to generate a scenario that encompasses the use of our Mos(kit)o device in the real world.  
+
With collaborations, public <B>education</B>, public <B>opinion</B>, <B>polling</B>, we were able to generate a <B>scenario</B> that encompasses the use of our Mos(kit)o device in the real world. </br>
Open science vs Start-up model  
+
 
From our meet-ups, discussion with other teams, and our own concern for the transition from Open Science to a possible start-up, we were able to generate two document tools that summarize and inform about these issues.  
+
<h2><B>Open science vs Start-up model</B></h2>
 +
<p>
 +
From our <B>meet-ups</B>, discussion with other teams, and our own concern for the transition from <B>Open Science</B> to a possible start-up, we were able to generate <a href="https://2016.igem.org/Team:Pasteur_Paris/Law"><B>two document tools</B></a> that summarize and inform about these issues. </br>
 
</p>
 
</p>
 
</div>
 
</div>

Revision as of 00:54, 20 October 2016